News

Gold rises as hopes for US-Iran diplomacy pause oil rally

Gold prices rose on Tuesday as investors weighed diplomatic efforts to ease the US-Iran conflict, which could temper oil-driven inflation risks and influence the US Federal Reserve’s interest rate path. Spot gold rose 0.9% to $4,042.69 per ounce as of 0345 GMT. US gold futures for August delivery were up 0.8% at $4,047.40. “It looks like gold is trying to find a base somewhere around this (

Stocks tumble at PSX as escalating tensions take toll on investor sentiments

Massive selling pressure was observed at the Pakistan Stock Exchange (PSX), as the United States and ​Iran expanded attacks in the Middle East, with the benchmark KSE-100 Index shedding nearly 2,000 points during the opening minutes of trading on Monday. At 9:33am, the benchmark index was hovering at 173,812.83, down by 1,989.95 points or 1.13%. Selling was witnessed in key sectors, includin

12 Pakistani firms sign investment deals to expand into Saudi Arabia

Twelve prominent Pakistani companies from various sectors have signed Memorandums of Understanding (MoUs) with Al Raee Group to launch operations and execute large-scale investments in Saudi Arabia. The agreements were signed at the "Saudi Company Formation and Business Expansion Summit 2026," organized by Al Raee Group in Islamabad, marking what organizers described as a significant milestone

Pakistan\'s external financing hits $16bn in FY26

Pakistan secured $4.04bn in external financing in June 2026, closing out FY26 (July 2025–June 2026) with a cumulative total of $16.16bn, the latest report by the Economic Affairs Division (EAD) showed. Disbursements from bilateral and multilateral development partners totalled $1.96bn in June, taking the full-year total to $6.39bn, while a $1.7bn commercial loan from China Development Bank was

40 drugs not available in market due to pending govt price approvals

Around 40 medicines that have already been registered in Pakistan remain unavailable to patients because the federal government has yet to approve their prices. The delay has left thousands of patients, including those battling cancer, diabetes and other life-threatening diseases, with limited treatment options, forcing many to depend on costly personal imports or smuggled and unregistered medi